| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, G-Protein-Coupled | 4 | 2006 | 167 | 0.520 |
Why?
|
| GTP-Binding Proteins | 10 | 2011 | 231 | 0.380 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 5 | 1999 | 26 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2003 | 250 | 0.320 |
Why?
|
| Signal Transduction | 13 | 2013 | 2688 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 8 | 2011 | 150 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 8 | 2011 | 147 | 0.310 |
Why?
|
| Arrestins | 6 | 2013 | 92 | 0.290 |
Why?
|
| src-Family Kinases | 4 | 2008 | 91 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2020 | 529 | 0.260 |
Why?
|
| Kallikreins | 2 | 2020 | 323 | 0.260 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 203 | 0.220 |
Why?
|
| ErbB Receptors | 3 | 2010 | 239 | 0.220 |
Why?
|
| Pyrimidines | 3 | 2008 | 178 | 0.200 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2018 | 76 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 3 | 2010 | 247 | 0.180 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2011 | 80 | 0.170 |
Why?
|
| Sulfonamides | 2 | 2008 | 141 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 1085 | 0.140 |
Why?
|
| beta-Arrestins | 5 | 2011 | 80 | 0.140 |
Why?
|
| Prekallikrein | 1 | 2015 | 66 | 0.140 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2015 | 54 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 2013 | 223 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2018 | 446 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 331 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 32 | 0.130 |
Why?
|
| Blood Glucose | 2 | 2014 | 631 | 0.120 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 3 | 2008 | 13 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 121 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 2 | 2011 | 107 | 0.110 |
Why?
|
| Enzyme Activation | 8 | 2010 | 791 | 0.110 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2013 | 17 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 938 | 0.110 |
Why?
|
| Angiotensin II | 2 | 2011 | 220 | 0.110 |
Why?
|
| Adenylyl Cyclases | 1 | 1992 | 94 | 0.110 |
Why?
|
| Biological Assay | 1 | 2013 | 88 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 807 | 0.110 |
Why?
|
| Biomarkers | 2 | 2014 | 1593 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1994 | 411 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2013 | 307 | 0.100 |
Why?
|
| Indazoles | 2 | 2008 | 12 | 0.100 |
Why?
|
| Protein Binding | 3 | 2013 | 1027 | 0.100 |
Why?
|
| Receptor, PAR-2 | 1 | 2010 | 7 | 0.100 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 30 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2013 | 483 | 0.090 |
Why?
|
| Phosphorylation | 9 | 2011 | 1199 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 292 | 0.090 |
Why?
|
| Animals | 16 | 2013 | 20877 | 0.090 |
Why?
|
| Calcium | 2 | 2013 | 929 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 226 | 0.090 |
Why?
|
| Risk Factors | 5 | 2020 | 5719 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 107 | 0.090 |
Why?
|
| Receptors, Adiponectin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Cell Line | 7 | 2008 | 1752 | 0.080 |
Why?
|
| Humans | 21 | 2020 | 68525 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 317 | 0.080 |
Why?
|
| Vitamin D | 1 | 2013 | 516 | 0.080 |
Why?
|
| Inflammation | 1 | 2014 | 1030 | 0.080 |
Why?
|
| Receptors, Cell Surface | 3 | 1999 | 248 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2020 | 2356 | 0.080 |
Why?
|
| Sulfones | 1 | 2007 | 45 | 0.080 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2006 | 6 | 0.070 |
Why?
|
| ras Proteins | 4 | 2008 | 102 | 0.070 |
Why?
|
| HEK293 Cells | 3 | 2013 | 326 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 183 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 562 | 0.070 |
Why?
|
| Protein Kinases | 2 | 1996 | 122 | 0.070 |
Why?
|
| Oxazoles | 1 | 2005 | 17 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2005 | 52 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 64 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 1996 | 214 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1995 | 100 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 1533 | 0.060 |
Why?
|
| Imidazoles | 1 | 2004 | 175 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 791 | 0.060 |
Why?
|
| Mice | 6 | 2013 | 8472 | 0.050 |
Why?
|
| Rats | 5 | 2010 | 5300 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2008 | 2673 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1070 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1997 | 195 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 1999 | 34 | 0.040 |
Why?
|
| Female | 6 | 2020 | 38015 | 0.040 |
Why?
|
| Transfection | 3 | 2013 | 782 | 0.040 |
Why?
|
| Male | 6 | 2020 | 37281 | 0.040 |
Why?
|
| Ligands | 2 | 2013 | 317 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2004 | 852 | 0.040 |
Why?
|
| Receptors, Catecholamine | 1 | 1998 | 2 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 3702 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.040 |
Why?
|
| Isoproterenol | 2 | 1999 | 163 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 78 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1054 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 5708 | 0.040 |
Why?
|
| beta-Arrestin 1 | 2 | 2011 | 22 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2008 | 190 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2008 | 304 | 0.030 |
Why?
|
| Cell Division | 2 | 2008 | 541 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2008 | 742 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2007 | 294 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1995 | 62 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2007 | 219 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 705 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2008 | 546 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 331 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 1994 | 8 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 2093 | 0.030 |
Why?
|
| Models, Biological | 3 | 2008 | 981 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 521 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 165 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2014 | 72 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2014 | 144 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 1994 | 128 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 2083 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 21119 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 330 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 105 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2014 | 158 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 765 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1046 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 191 | 0.030 |
Why?
|
| Drug Design | 1 | 2013 | 107 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1992 | 153 | 0.030 |
Why?
|
| Bias | 1 | 2013 | 148 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 866 | 0.030 |
Why?
|
| Phosphotyrosine | 2 | 2007 | 41 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 175 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 159 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 1082 | 0.030 |
Why?
|
| Histone Chaperones | 1 | 2011 | 11 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 29 | 0.030 |
Why?
|
| beta-Arrestin 2 | 1 | 2011 | 29 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2006 | 523 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 57 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 1446 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3256 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2014 | 458 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1992 | 202 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 67 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2010 | 18 | 0.020 |
Why?
|
| ADAM17 Protein | 1 | 2010 | 28 | 0.020 |
Why?
|
| EGF Family of Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Amphiregulin | 1 | 2010 | 19 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 880 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2010 | 53 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2011 | 110 | 0.020 |
Why?
|
| Tyrosine | 3 | 1997 | 196 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 904 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 361 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 21375 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 146 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2015 | 1447 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1419 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2005 | 420 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 238 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1582 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2008 | 12 | 0.020 |
Why?
|
| Adiponectin | 1 | 2008 | 52 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 62 | 0.020 |
Why?
|
| src Homology Domains | 2 | 1999 | 29 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 7 | 0.020 |
Why?
|
| raf Kinases | 1 | 2007 | 6 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 34 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 14842 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 266 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2007 | 43 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 73 | 0.020 |
Why?
|
| COS Cells | 2 | 1998 | 155 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 48 | 0.020 |
Why?
|
| Cornea | 1 | 2007 | 76 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2008 | 397 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 308 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 246 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 1015 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 753 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 434 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2004 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 839 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 320 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 123 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 54 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 498 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.020 |
Why?
|
| Solubility | 1 | 2005 | 134 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2006 | 305 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 693 | 0.020 |
Why?
|
| Dogs | 1 | 2005 | 490 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 314 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 631 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1745 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 8903 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7028 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 1849 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 384 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 659 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 508 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7335 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 1173 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 1999 | 16 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 88 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1999 | 92 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 97 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1998 | 12 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1998 | 65 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 60 | 0.010 |
Why?
|
| CHO Cells | 1 | 1998 | 161 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 262 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1997 | 67 | 0.010 |
Why?
|
| Mitogens | 1 | 1997 | 45 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 2550 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 1660 | 0.010 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 1996 | 5 | 0.010 |
Why?
|
| Son of Sevenless Proteins | 1 | 1995 | 4 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1995 | 13 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1995 | 26 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1995 | 95 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1996 | 597 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1992 | 12 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1992 | 35 | 0.010 |
Why?
|
| Fluorides | 1 | 1992 | 15 | 0.010 |
Why?
|
| Proteins | 1 | 1995 | 473 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1992 | 362 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1995 | 617 | 0.010 |
Why?
|